Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supreme Court Upholds IPR Standard Making Patent Invalidation Easier; Will Congress Reverse?

This article was originally published in The Pink Sheet Daily

Executive Summary

High court says inconsistent decisions by Patent Trial and Appeal Board and district court are okay; House and Senate bills would eliminate the broad standard but opposition by tech community could doom passage.


Related Content

PTO Final Rule Dropping BRI Patent Claim Standard Offers No Deference To District Courts
US Patent Reform Debate: Proposal To Eliminate BRI Patent Claim Standard Splits Stakeholders
Judge Kavanaugh May Be Good US Supreme Court Pick For Pharma
Despite Supreme Court Win, PTO Moves To Drop BRI Patent Claim Standard
Inter Partes Patent Challenges Are Constitutional, US Supreme Court Rules
Court Gives Biopharma Patent Owners (A Little) Help In Inter Partes Review
Patent Day At The Supreme Court: A Split Decision On Split Decisions?
Supreme Court Seems Likely To Keep Inter Partes Review Despite Problems
Will Inter Partes Review Go Away? Supreme Court Weighs Fate
Court Ruling May Help Life-Science Firms In IPR Patent Battles





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts